首頁 > 市場調查報告書 > 製藥

藥物開發開發業務受託機關

市場調查報告書

商品編碼

1490178

全球藥品契約製造市場：按服務類型、分子類型和地區分類

Contract Pharmaceutical Manufacturing Market, By Service Type, By Molecule Type, By Geography

出版日期: 2024年05月15日 | 出版商:

Coherent Market Insights | 英文 224 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球藥品契約製造市場規模將達2,113.4億美元，2024年至2031年複合年成長率為9.70%，2031年將達4034.5億美元。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	2113.4億美元
實際資料	2019-2023	預測期	2024-2031
預測 2024-2031 年複合年成長率：	9.70%	2031 年金額預測	4034.5億美元

圖：按地區分類的藥品契約製造市場佔有率（%）（2024年）

全球藥品契約製造市場在過去幾年中穩步成長。契約製造是指將某些製藥流程（例如製造、包裝和測試）外包給稱為契約製造組織（CMO）的第三方公司。降低製造成本和關注核心能力的需求日益成長，是製藥公司將製造需求外包給 CMO 的主要驅動力。此外，專利到期帶來的持續損失、學名藥需求的增加以及藥物開發和商業化活動外包的增加預計將在未來幾年塑造全球契約製造市場，從而進一步支持成長。

市場動態：

全球藥品契約製造市場的成長是由心血管疾病盛行率上升以及世界上心律不整風險較高的老年人口不斷成長所推動的。根據世界衛生組織 (WHO) 的資料，心血管疾病是全球第一大死因，每年有超過 1700 萬人死於心臟病和中風。此外，專注於小型化和更長電池壽命的技術創新正在擴大心律調節器植入的適應症。然而，心律調節器手術相關的高成本以及導線缺陷和感染等裝置併發症的風險可能會阻礙市場成長。

本研究的主要特點

該報告對全球藥品契約製造市場進行了詳細分析，並提供了以 2023 年為基準年的預測期（2024-2031 年）的市場規模（十億美元）和平均年成長率（CAGR%）。
它還強調了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球藥品契約製造市場的主要企業。
主要企業包括 Lonza Group、Boehringer Ingelheim GmbH、Genpact Limited、Accenture plc、Quintiles Transnational Corporation、Baxter、Dr. Reddy's Laboratories Ltd.、Aurobindo Pharma、Pfizer, Inc.、The Almac Group、Teva Pharmaceutical Industries Ltd.、Piramal Enterprises Ltd. .、Covance, Inc.、Catalent, Inc.、Abbvie, Inc.、Celltrion 等。
該報告的見解將幫助負責人和公司經營團隊就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球藥品契約製造市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球藥品契約製造市場的各種策略矩陣，將有助於相關人員做出決策。

Contract Manufacturing Organization (CMO)
API Manufacturing
Final dosage form manufacturing
Packaging
Contract Research Organization (CRO)
Drug Discovery
Preclinical Studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical Coding and Writing
Monitoring
Clinical Data Management
其他（協議開發）

第6章全球藥品契約製造市場，依分子類型，2019-2031（十億美元）

低分子
高分子

第7章 2019-2031 年全球藥品契約製造市場（按地區）（十億美元）

第8章競爭格局

公司簡介
- Lonza Group
- Boehringer Ingelheim GmbH
- Genpact Limited
- Accenture plc
- Quintiles Transnational Corporation
- Baxter
- Dr. Reddy's Laboratories Ltd.
- Aurobindo Pharma
- Pfizer, Inc.
- The Almac Group
- Teva Pharmaceutical Industries Ltd.
- Piramal Enterprises Ltd.
- Covance, Inc.
- Catalent, Inc.
- Abbvie, Inc.
- Celltrion

第9章分析師建議

第10章參考文獻與調查方法

簡介目錄

Product Code: CMI2397

Global contract pharmaceutical manufacturing market is estimated to be valued at USD 211.34 Bn in 2024 and is expected to reach USD 403.45 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.7% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 211.34 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	9.70%	2031 Value Projection:	US$ 403.45 Bn

Figure. Contract Pharmaceutical Manufacturing Market Share (%), By Region, 2024

Contract Pharmaceutical Manufacturing Market - IMG1

The global contract pharmaceutical manufacturing market has been witnessing steady growth over the past few years. Contract pharmaceutical manufacturing refers to the outsourcing of certain pharmaceutical processes such as manufacturing, packaging, and testing of pharmaceutical drugs to a third party company known as contract manufacturing organizations (CMOs). The growing need to reduce manufacturing costs and focus on core competencies are some of the key factors driving pharmaceutical companies to outsource their production requirements to CMOs. In addition, continued patent cliff losses, rising demand for generic drugs, and increasing outsourcing of drug development and commercialization activities are further expected to support the growth of the global contract pharmaceutical manufacturing market in the coming years.

Market Dynamics:

The global contract pharmaceutical manufacturing market growth is driven by rising incidence of cardiovascular diseases and increasing elderly population base globally who are at high risk of arrhythmias. According to the data by World Health Organization, cardiovascular diseases are the leading cause of deaths worldwide with over 17 million lives lost each year due to heart attacks and strokes. Moreover, technological innovations with focus on miniaturization and battery longevity have expanded indications for pacemaker implants. However, high costs associated with pacemaker procedures and risk of device complications such as lead defects and infections can hamper the market growth.

Key Features of the Study:

This report provides an in-depth analysis of the global contract pharmaceutical manufacturing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global contract pharmaceutical manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Lonza Group, Boehringer Ingelheim GmbH, Genpact Limited, Accenture plc, Quintiles Transnational Corporation, Baxter , Dr. Reddy's Laboratories Ltd., Aurobindo Pharma, Pfizer, Inc., The Almac Group, Teva Pharmaceutical Industries Ltd., Piramal Enterprises Ltd., Covance, Inc., Catalent, Inc., Abbvie, Inc., and Celltrion.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global contract pharmaceutical manufacturing market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contract pharmaceutical manufacturing market.

Detailed Segmentation-

By Service Type:
- Contract Manufacturing Organization (CMO)
- API Manufacturing
- Final dosage form manufacturing
- Packaging
- Contract Research Organization (CRO)
- Drug Discovery
- Preclinical Studies
- Early Phase I - IIa
- Phase IIa - III
- Phase IIIb - IV
- Medical Coding and Writing
- Monitoring
- Clinical Data Management
- Others (Protocol Development, etc.)
By Molecule Type:
- Small Molecule
- Large Molecule
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Lonza Group
- Boehringer Ingelheim GmbH
- Genpact Limited
- Accenture plc
- Quintiles Transnational Corporation
- Baxter
- Reddy's Laboratories Ltd.
- Aurobindo Pharma
- Pfizer, Inc.
- The Almac Group
- Teva Pharmaceutical Industries Ltd.
- Piramal Enterprises Ltd.
- Covance, Inc.
- Catalent, Inc.
- Abbvie, Inc.
- Celltrion

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By Molecule Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Contract Pharmaceutical Manufacturing Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Contract Pharmaceutical Manufacturing Market, By Service Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Contract Manufacturing Organization (CMO)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
API Manufacturing
Final dosage form manufacturing
Packaging
Contract Research Organization (CRO)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Drug Discovery
Preclinical Studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical Coding and Writing
Monitoring
Clinical Data Management
Others (Protocol Development, etc.)

6. Global Contract Pharmaceutical Manufacturing Market, By Molecule Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Small Molecule
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Large Molecule
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Contract Pharmaceutical Manufacturing Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Lonza Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim GmbH
- Genpact Limited
- Accenture plc
- Quintiles Transnational Corporation
- Baxter
- Dr. Reddy's Laboratories Ltd.
- Aurobindo Pharma
- Pfizer, Inc.
- The Almac Group
- Teva Pharmaceutical Industries Ltd.
- Piramal Enterprises Ltd.
- Covance, Inc.
- Catalent, Inc.
- Abbvie, Inc.
- Celltrion